SS Innovations International (SSII) Asset Writedowns and Impairment (2024 - 2025)
SS Innovations International recorded quarterly Asset Writedowns and Impairment of $82942.0 in Q4 2025, down 82.36% quarter-over-quarter from $470249.0 in Q3 2025, and down 64.71% year-over-year from $235030.0 in Q4 2024.
SS Innovations International's Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at $82942.0 for Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment fell 64.71% year-over-year to $82942.0; the TTM figure through Dec 2025 stood at $324345.0 (down 66.06% YoY), while the FY2025 annual figure was $324345.0, down 66.06% from the prior year.
- Asset Writedowns and Impairment came in at $82942.0 for Q4 2025 at SS Innovations International, down from $470249.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $470249.0 in Q3 2025 to a low of -$422711.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 82,942.00 |
| Dec 31, 2025 | 82,942.00 |
| Sep 30, 2025 | 470,249.00 |
| Sep 30, 2025 | 470,249.00 |
| Jun 30, 2025 | 193,865.00 |
| Jun 30, 2025 | 193,865.00 |
| Mar 31, 2025 | -422,711.00 |
| Mar 31, 2025 | -422,711.00 |
| Dec 31, 2024 | 235,030.00 |
| Dec 31, 2024 | 235,030.00 |
| Sep 30, 2024 | 147,684.00 |
| Sep 30, 2024 | 147,684.00 |
| Jun 30, 2024 | 183,718.00 |
| Jun 30, 2024 | 183,718.00 |
| Mar 31, 2024 | 389,330.00 |
| Mar 31, 2024 | 389,330.00 |